TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Lesley F. Portnoy
Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors

The Portnoy Law Firm is advising aTyr Pharma investors about a potential class action lawsuit related to securities purchased between January 16 and September 12, 2025, following a failed Phase 3 clinical trial for efzofitimod.

Insights
ATYR   negative

Stock price fell sharply after announcing that their Phase 3 clinical trial for efzofitimod failed to meet its primary endpoint, indicating significant negative business impact